Search

Robert A. Zeman

Examiner (ID: 12430, Phone: (571)272-0866 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645, 1643
Total Applications
1326
Issued Applications
557
Pending Applications
268
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13413701 [patent_doc_number] => 20180258393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-13 [patent_title] => METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES [patent_app_type] => utility [patent_app_number] => 15/981332 [patent_app_country] => US [patent_app_date] => 2018-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981332 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/981332
Method for ex-vivo expansion of regulatory T cells with enhanced suppressive function for clinical application in immune mediated diseases May 15, 2018 Issued
Array ( [id] => 13447167 [patent_doc_number] => 20180275126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => POLYVALENT CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN [patent_app_type] => utility [patent_app_number] => 15/976938 [patent_app_country] => US [patent_app_date] => 2018-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37675 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15976938 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/976938
Polyvalent chimeric OspC vaccinogen and diagnostic antigen May 10, 2018 Issued
Array ( [id] => 20157011 [patent_doc_number] => 12383609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-12 [patent_title] => Plasmodium sporozoite NPDP peptides as vaccine and target novel malaria vaccines and antibodies binding to [patent_app_type] => utility [patent_app_number] => 16/606207 [patent_app_country] => US [patent_app_date] => 2018-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 53821 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606207 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/606207
Plasmodium sporozoite NPDP peptides as vaccine and target novel malaria vaccines and antibodies binding to Apr 18, 2018 Issued
Array ( [id] => 13374617 [patent_doc_number] => 20180238850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => DETECTION METHOD [patent_app_type] => utility [patent_app_number] => 15/956315 [patent_app_country] => US [patent_app_date] => 2018-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2916 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956315 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/956315
DETECTION METHOD Apr 17, 2018 Abandoned
Array ( [id] => 13986507 [patent_doc_number] => 20190062411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => MRKA POLYPEPTIDES, ANTIBODIES, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/940344 [patent_app_country] => US [patent_app_date] => 2018-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41318 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15940344 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/940344
MRKA POLYPEPTIDES, ANTIBODIES, AND USES THEREOF Mar 28, 2018 Abandoned
Array ( [id] => 13462565 [patent_doc_number] => 20180282825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => PROBIOTIC BIFIDOBACTERIUM STRAIN [patent_app_type] => utility [patent_app_number] => 15/936661 [patent_app_country] => US [patent_app_date] => 2018-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11239 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15936661 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/936661
Probiotic bifidobacterium strain Mar 26, 2018 Issued
Array ( [id] => 16748843 [patent_doc_number] => 20210100852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => Novel Bifidobacterium Genus Bacterium [patent_app_type] => utility [patent_app_number] => 16/498148 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9870 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498148 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/498148
None Mar 22, 2018 Issued
Array ( [id] => 15557509 [patent_doc_number] => 20200063166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => ZINC BINUCLEAR CLUSTER TRANSCRIPTIONAL REGULATOR-DEFICIENT STRAIN [patent_app_type] => utility [patent_app_number] => 16/493017 [patent_app_country] => US [patent_app_date] => 2018-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30038 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 317 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493017 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/493017
ZINC BINUCLEAR CLUSTER TRANSCRIPTIONAL REGULATOR-DEFICIENT STRAIN Mar 11, 2018 Abandoned
Array ( [id] => 18732572 [patent_doc_number] => 11801292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-31 [patent_title] => Polypeptide epitopes of [patent_app_type] => utility [patent_app_number] => 16/486937 [patent_app_country] => US [patent_app_date] => 2018-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 10295 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486937 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/486937
Polypeptide epitopes of Feb 15, 2018 Issued
Array ( [id] => 15254195 [patent_doc_number] => 20190375831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-12 [patent_title] => NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE [patent_app_type] => utility [patent_app_number] => 16/485354 [patent_app_country] => US [patent_app_date] => 2018-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35385 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485354 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/485354
Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use Feb 11, 2018 Issued
Array ( [id] => 16893202 [patent_doc_number] => 11034735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Hybrid peptide, set of hybrid peptides, composition, uses of the hybrid peptide, method for inducing an immune response and kits [patent_app_type] => utility [patent_app_number] => 16/485035 [patent_app_country] => US [patent_app_date] => 2018-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22556 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485035 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/485035
Hybrid peptide, set of hybrid peptides, composition, uses of the hybrid peptide, method for inducing an immune response and kits Feb 8, 2018 Issued
Array ( [id] => 18302054 [patent_doc_number] => 11623945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-11 [patent_title] => Immunostimulating compositions and uses therefore [patent_app_type] => utility [patent_app_number] => 16/483806 [patent_app_country] => US [patent_app_date] => 2018-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34430 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483806 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/483806
Immunostimulating compositions and uses therefore Feb 5, 2018 Issued
Array ( [id] => 14810175 [patent_doc_number] => 20190271697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-05 [patent_title] => Modified Indirect Enzyme Linked Immunosorbent Assay Optimal for Monitoring Acute and Long Term Carrier Infections of Diverse Babesia bovis Strains [patent_app_type] => utility [patent_app_number] => 15/886915 [patent_app_country] => US [patent_app_date] => 2018-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10056 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886915 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/886915
Modified Indirect Enzyme Linked Immunosorbent Assay Optimal for Monitoring Acute and Long Term Carrier Infections of Diverse Babesia bovis Strains Feb 1, 2018 Abandoned
Array ( [id] => 12908935 [patent_doc_number] => 20180194820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/883999 [patent_app_country] => US [patent_app_date] => 2018-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21140 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15883999 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/883999
Anti-inflammatory compounds and methods of use Jan 29, 2018 Issued
Array ( [id] => 15296021 [patent_doc_number] => 20190391146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => Methods of Detecting and Diagnosing Tuberculosis Using Anti-MTLDL Antibodies [patent_app_type] => utility [patent_app_number] => 16/481025 [patent_app_country] => US [patent_app_date] => 2018-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481025 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/481025
Methods of Detecting and Diagnosing Tuberculosis Using Anti-MTLDL Antibodies Jan 24, 2018 Abandoned
Array ( [id] => 17192124 [patent_doc_number] => 11160856 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-02 [patent_title] => Vaccine against [patent_app_type] => utility [patent_app_number] => 15/878491 [patent_app_country] => US [patent_app_date] => 2018-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 12415 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878491 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/878491
Vaccine against Jan 23, 2018 Issued
Array ( [id] => 15345247 [patent_doc_number] => 20200010515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => RECOMBINANT VACCINE AGAINST HELMINTHS IN PICHIA PASTORIS AND METHODS FOR PRODUCING AND PURIFYING PROTEINS FOR USE AS VACCINES AGAINST HELMINTHS [patent_app_type] => utility [patent_app_number] => 16/478521 [patent_app_country] => US [patent_app_date] => 2018-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478521 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/478521
RECOMBINANT VACCINE AGAINST HELMINTHS IN PICHIA PASTORIS AND METHODS FOR PRODUCING AND PURIFYING PROTEINS FOR USE AS VACCINES AGAINST HELMINTHS Jan 21, 2018 Abandoned
Array ( [id] => 13490227 [patent_doc_number] => 20180296656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => CHIMERIC OSPA GENES, PROTEINS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/875479 [patent_app_country] => US [patent_app_date] => 2018-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41364 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875479 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/875479
Chimeric OspA genes, proteins and methods of use thereof Jan 18, 2018 Issued
Array ( [id] => 12750439 [patent_doc_number] => 20180141980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => TREPONEMA PALLIDUM TRIPLET ANTIGEN [patent_app_type] => utility [patent_app_number] => 15/865594 [patent_app_country] => US [patent_app_date] => 2018-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8273 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15865594 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/865594
Treponema pallidum triplet antigen Jan 8, 2018 Issued
Array ( [id] => 17177374 [patent_doc_number] => 11154603 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-10-26 [patent_title] => Burkholderia pseudomallei composition [patent_app_type] => utility [patent_app_number] => 15/864268 [patent_app_country] => US [patent_app_date] => 2018-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4882 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15864268 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/864268
Burkholderia pseudomallei composition Jan 7, 2018 Issued
Menu